REFERENCES
- Badenoch PR. The pathogenesis of Acanthamoeba keratitis. Aust NZ J Ophthalmol 1991; 19: 9–19.
- Kilvington S. Acanthamoeba trophozoite and cyst adherence to four types of soft contact lens and removal by cleaning agents. Eye 1993; 7: 535–538.
- Stehr‐green JK, Bailey TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol 1989; 107: 331–336.
- Radford CF, Minassian DC, Dart JK. Acanthamoeba keratitis in England and Wales: incidence, outcome and risk factors. Br J Ophthalmol 2002; 86: 536–542.
- Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995; 79: 1078–1082.
- Seal DV. Acanthamoeba keratitis update: incidence, molecular epidemiology and new drugs for treatment. Eye 2003; 17: 893–905.
- Radford CF, Lehmann OJ, Dart JKG. Acanthamoeba keratitis: multi‐centre survey in England 1992–1996. Br J Ophthalmol 1998; 82: 1387–1392.
- Illingworth CD, Cook SD. Acanthamoeba keratitis. Surv Ophthalmol 1998; 42: 493–508.
- O’day DM, Head WS. Advances in the management of keratomycosis and Acanthamoeba keratitis. Cornea 2000; 19: 681–687.
- Ficker LA, Kirkness C, Wright P. Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 1993; 100: 105–110.
- Duguid JGM, Dart JKG, Morlet N, Allan BDS, Matheson M, Ficker L, Tuft S. Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 1997; 104: 1587–1592.
- Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99: 185–191.
- Moore MB, Mcculley JP, Luckenbach M, Gelender H, Newton C, Mcdonald MB, Visvesvara GS. Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol 1985; 100: 396–403.
- Mcculley JP, Alizadeh H, Niederhorn JY. The diagnosis and management of Acanthamoeba keratitis. CLAO J 2000; 26: 47–51.
- Larkin DFP, Kilvington S, Easty DL. Contamination of contact lens storage cases by Acanthamoeba and bacteria. Br J Ophthalmol 1990; 74: 133–135.
- Gray TB, Cursons RTM, Sherwan JF, Rose PR. Acanthamoeba, bacterial and fungal contamination of contact lens storage cases. Br J Ophthalmol 1995; 79: 601–605.
- John T, Desai D, Sahm D. Adherence of Acanthamoeba castellanii cysts and trophozoites to unworn contact lenses. Am J Ophthalmol 1989; 108: 658–664.
- Sharma S, Ramachandran L, Rao GN. Adherence of cysts and trophozoites of Acanthamoeba to unworn rigid gas permeable and soft contact lenses. CLAO J 1995; 21: 247–251.
- Tomlinson A, Simmons PA, Seal DV, Mcfadyen AK. Salicylate inhibition of Acanthamoeba attachment to contact lenses. Ophthalmology 2000; 107: 112–117.
- Niszl IA, Markus MB. Anti‐Acanthamoeba activity of contact lens solutions. Br J Ophthalmol 1998; 82: 1033–1038.
- Hughes R, Heaselgrave W, Kilvington S. Acanthamoeba polyphagia strain age and method of cyst production influence the observed efficacy of therapeutic agents and contact lens disinfectants. Antimicrob Agents Chemother 2003; 47: 3080–3084.
- Buck SL, Rosenthal RA, Schlech BA. Methods used to evaluate the effectiveness of contact lens care solutions and other compounds against Acanthamoeba: a review of the literature. CLAO J 2000; 26: 72–84.
- Kilvington S, Anger C. A comparison of cyst age and assay method of the efficacy of contact lens disinfectants against Acanthamoeba. Br J Ophthalmol 2001; 85: 336–340.
- Silvany RE, Dougherty JM, Mcculley JP. Effect of contact lens preservatives on Acanthamoeba. Ophthalmology 1991; 98: 854–857.
- Papadimitriou JT. Complications of preservatives in contact lens solutions. Aust J Optom 1983; 66: 220–226.
- Silvany RE, Dougherty JM, Mcculley JP, Wood TS, Bowman RW, Moore MB. The effect of currently available contact lens disinfection systems on Acanthamoeba castellanii and Acanthamoeba polyphaga. Ophthalmology 1990; 97: 286–290.
- Connor CG, Hopkins SL, Salisbury RD. Effectivity of contact lens disinfection systems against Acanthamoeba culbertsoni. Optom Vis Sci 1991; 68: 138–141.
- Begley CG, Weirich B, Benak J, Pence NA. Effects of rigid gas permeable contact lens solutions on the human corneal epithelium. Optom Vis Sci 1992; 69: 347–353.
- Rosenthal RA, Mcanally CL, Mcnamee LS, Buck SL, Schlitzer RL, Stone RP. Broad spectrum antimicrobial activity of a new multi‐purpose disinfecting solution. CLAO J 2000; 26: 120–126.
- Marshall E, Begley C, Nguyen C. Frequency of complications among wearers of disposable and conventional soft contact lenses. Int Contact Lens Clin 1992; 19: 55–59.
- Jones L. Disposable contact lenses: a review. J Br Contact Lens Assoc 1994; 17: 43–49.
- Bottone EJ, Madayag RM, Qureshi MN. Acanthamoeba keratitis: synergy between amoebic and bacterial co‐contaminants in contact lens care systems as a prelude to infection. J Clin Microbiol 1992; 30: 2447–2450.
- George M. MicroBlock: the new antimicrobial lens case. Optician 2003; 226(5930): 18–20.
- Watt K, Swarbrick HA. Microbial keratitis in overnight orthokeratology: review of the first 50 cases. Eye Contact Lens 2005; 31: 201–208.
- Niyadurupola N, Illingworth CD. Acanthamoeba keratitis associated with misuse of daily disposable contact lenses. Cont Lens Anterior Eye 2006; 29: 269–271.
- Gagnon MR, Walter KA. A case of Acanthamoeba keratitis as a result of a cosmetic contact lens. Eye Contact Lens 2006; 32: 37–38.
- Murdoch D, Gray TB, Cursons R, Parr D. Acanthamoeba keratitis in New Zealand, including two cases with in vivo resistance to polyhexamethylene biguanide. Aust NZ J Ophthalmol 1998; 26: 231–236.
- Tay‐kearney M, Mcghee CNJ, Crawford GJ, Trown K. Acanthamoeba keratitis: a masquerade of presentation in six cases. Aust NZ J Ophthalmol 1993; 21: 237–245.
- Auran JD, Starr MB, Jakobiec FA. Acanthamoeba keratitis: a review of the literature. Cornea 1987; 6: 2–26.
- Kanski JJ. Clinical Ophthalmology, 4th ed. London: Butterworth Heinemann, 2000. p 106–108.
- Nakano E, Oliveira M, Portellinha W, De freitas D, Nakano K. Confocal microscopy in early diagnosis of Acanthamoeba keratitis. J Refract Surg 2004; 20: S737–S740.
- Lim L, Coster DJ, Badenoch PR. Antimicrobial susceptibility of 19 Australian corneal isolates of Acanthamoeba. Clin Experiment Ophthalmol 2000; 28: 119–124.
- Seal DV, Hay J, Kirkness CM, Wright P. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 1996; 10: 413–421.
- Bacon AS, Dart JKG, Ficker LA, Matheson MM, Wright P. Acanthamoeba keratitis: the value of early diagnosis. Ophthalmology 1993; 100: 1238–1243.
- Driebe WT, Stern GA, Epstein RJ, Visvesvara GS, Adi M, Komadina T. Acanthamoeba keratitis: potential role for topical clotrimazole in combination chemotherapy. Arch Ophthalmol 1988; 106: 1196–1201.
- Berger ST, Mondino BJ, Hoft RH, Donzis PB, Holland GN, Farley MK, Levinson JE. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 1990; 110: 395–403.
- Brooks JG, Coster DJ, Badenoch PR (1994). Acanthamoeba keratitis: resolution after epithelial debridement. Cornea 1994; 13: 186–189.